Gregory Batcheller
STRATEGIC ADVISOR AND CHAIRMAN OF THE BOARD
MANGEMENT TEAM
Xintela
Sweden
Biography
LL.M, J.D., B.Sc. (Econ) Strategic advisor and chairman of the board since 2011. Extensive experience from the pharmaceutical, biotechnical and medical technical industries, such as CEO for Pulsetten AB (which sold DuoCort Pharma AB to ViroPharma Inc in 2011) and a partner in PULS (Partners for Development investments in Life Sciences). Board chairman for Neurovive Pharmaceutical AB and Monocl AB.
Research Interest
Business